FEB 13, 2020 5:04 AM PST

Protein that suppresses immune system linked to lupus

WRITTEN BY: Tara Fernandez

 

A study published in Human Immunology has described, for the first time, a link between an immunosuppressive protein on the surface of T cells and the development of systemic lupus erythematosus, or SLE. This protein, human leukocyte antigen G (HLA-G), is expressed on fetal derived placental cells and is thought to play a role in immune tolerance during pregnancy.

HLA-G has been the subject of intense study in the last two decades. In particular, scientists have been interested in how HLA-G-mediated pathways affect rejection after organ transplantation, or how tumors suppress hijack these to evade immune detection. 

Now, the research team led by Francesco Puppo at the University of Genoa has identified that patients with SLE have significantly elevated levels of HLA-G. The protein was found on the membrane of peripheral blood mononuclear cells, a subset of white blood cells that includes T cells and monocytes. The significant difference in HLA-G levels between lupus patients and healthy controls points to the protein’s possible involvement in the onset or progression of this autoimmune disease.

SLE affects nearly every organ system from the skin, joints and central nervous system to the brain and kidneys. The disease is more prevalent in women than men and is thought to be a result of complex genetic, environmental and hormonal factors. Lupus is characterized by an exaggerated immune response to the body’s own cells and tissues, causing this widespread organ damage.

 

 

Based on their findings, the authors hypothesize that the increased production of HLA-G on the surface of immune cells could reflect an attempt to control the imbalanced immune responses occurring during the systemic autoimmune diseases.

Further clinical studies are due to establish whether HLA-G could be leveraged for diagnostic or therapeutic purposes.

 

Sources: Scleroderma News, Human Immunology.

 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
AUG 12, 2020
Immunology
Is Gluten Becoming More Immunoreactive?
AUG 12, 2020
Is Gluten Becoming More Immunoreactive?
In recent years, the number of people diagnosed with celiac disease has increased drastically, even with many undiagnose ...
SEP 06, 2020
Microbiology
Small Changes in Vaccine Molecules Could Make Them More Effective
SEP 06, 2020
Small Changes in Vaccine Molecules Could Make Them More Effective
Effective vaccines have to trigger an immune response, which is intended to create an immune 'memory' of a specific infe ...
SEP 11, 2020
Immunology
Study Reveals Tumor Defense Mechanism... And How to Beat It
SEP 11, 2020
Study Reveals Tumor Defense Mechanism... And How to Beat It
  P53 is an infamous process gene at the core of the development of tumors.  When P53  functional, it pau ...
OCT 08, 2020
Immunology
Air Pollution Particles Detected in the Placenta, Immune Cells Mop Them Up
OCT 08, 2020
Air Pollution Particles Detected in the Placenta, Immune Cells Mop Them Up
Tiny, black particles much like those found in polluted air have been found in the placentas of pregnant women, as repor ...
NOV 09, 2020
Microbiology
Fighting COVID-19 with Help From Llamas
NOV 09, 2020
Fighting COVID-19 with Help From Llamas
Camelids, which include llamas, alpacas and camels have immune systems that generate two kinds of antibodies when confro ...
NOV 16, 2020
Immunology
Australian COVID-19 vaccine is promising and could be released next year
NOV 16, 2020
Australian COVID-19 vaccine is promising and could be released next year
Pharmaceutical companies worldwide are racing to develop a COVID-19 vaccine that will hopefully end this pandemic and he ...
Loading Comments...